Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis

Digestive Diseases and Sciences

Volumn 61, Issue 3, 2016, Pages 881-889

  Ou, Baochi ^a   Zhao, Jingkun ^a   Guan, Shaopei ^a   Lu, Aiguo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; Inflammatory bowel disease; Meta analysis; Survival

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; CONFIDENCE INTERVAL; CROHN DISEASE; HAZARD RATIO; HUMAN; INFLAMMATORY BOWEL DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; SAMPLE SIZE; SENSITIVITY ANALYSIS; ULCERATIVE COLITIS; CARCINOMA; CASE CONTROL STUDY; COLON; COLORECTAL NEOPLASMS; COMORBIDITY; INFLAMMATORY BOWEL DISEASES; META ANALYSIS; MORTALITY; ODDS RATIO; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

CARCINOMA; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; COMORBIDITY; HUMANS; INFLAMMATORY BOWEL DISEASES; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 84958948141     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-015-3940-1     Document Type: Article

References (40)

1. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–535.
2. Maykel JA, Hagerman G, Mellgren AF, et al. Crohn’s colitis: the incidence of dysplasia and adenocarcinoma in surgical patients. Dis Colon Rectum. 2006;49:950–957.
3. Gillen CD, Walmsley RS, Prior P, et al. Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis. Gut. 1994;35:1590–1592.
4. Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology. 2013;145:166.e8–175.e8.
5. Lindstrom L, Lapidus A, Ost A, Bergquist A. Increased risk of colorectal cancer and dysplasia in patients with Crohn’s colitis and primary sclerosing cholangitis. Dis Colon Rectum. 2011;54:1392–1397.
6. Farraye FA, Odze RD, Eaden J, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:738–745.
7. van Heerden JA, Beart RW Jr. Carcinoma of the colon and rectum complicating chronic ulcerative colitis. Dis Colon Rectum. 1980;23:155–159.
8. Gyde SN, Prior P, Thompson H, et al. Survival of patients with colorectal cancer complicating ulcerative colitis. Gut. 1984;25:228–231.
9. Delaunoit T, Limburg PJ, Goldberg RM, et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:335–342.
10. Gearhart SL, Nathan H, Pawlik TM, et al. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: a surveillance epidemiology and end results medicare study. Dis Colon Rectum. 2012;55:270–277.
11. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
12. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815–2834.
13. Wells GA, Shea B, O’Connell D et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. January 10 2011. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
16. Brackmann S, Aamodt G, Andersen SN, et al. Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer. Inflamm Bowel Dis. 2010;16:474–481.
17. Shu X, Ji J, Sundquist J, et al. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011;17:816–822.
18. Herrinton LJ, Liu L, Levin TR, et al. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–389.
19. Ording AG, Horvath-Puho E, Erichsen R, et al. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn’s disease: a nationwide population-based cohort study. Inflamm Bowel Dis. 2013;19:800–805.
20. Watanabe T, Konishi T, Kishimoto J, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17:802–808.
21. Ali RA, Dooley C, Comber H, et al. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:584.e1-2–589.e1-2.
22. Hrabe JE, Byrn JC, Button AM, et al. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome. J Surg Oncol. 2014;109:117–121.
23. Kiran RP, Khoury W, Church JM, et al. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn’s and ulcerative colitis based on three decades of experience. Ann Surg. 2010;252:330–335.
24. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287:G7–G17.
25. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532.
26. Tarmin L, Yin J, Harpaz N, et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res. 1995;55:2035–2038.
27. Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950–954.
28. Redston MS, Papadopoulos N, Caldas C, et al. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology. 1995;108:383–392.
29. Foran E, Garrity-Park MM, Mureau C, et al. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6. Mol Cancer Res. 2010;8:471–481.
30. O’Sullivan JN, Bronner MP, Brentnall TA, et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet. 2002;32:280–284.
31. Hemminki K, Li X, Sundquist J, Sundquist K. Cancer risks in ulcerative colitis patients. Int J Cancer. 2008;123:1417–1421.
32. Hemminki K, Li X, Sundquist J, Sundquist K. Cancer risks in Crohn disease patients. Ann Oncol. 2009;20:574–580.
33. Ohman U. Colorectal carcinoma in patients with ulcerative colitis. Am J Surg. 1982;144:344–349.
34. Jensen AB, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol. 2006;101:1283–1287.
35. Larsen M, Mose H, Gislum M, et al. Survival after colorectal cancer in patients with Crohn’s disease: a nationwide population-based Danish follow-up study. Am J Gastroenterol. 2007;102:163–167.
36. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274–1282.
37. Aarnio MH, Mustonen JP, Mecklin, et al. Prognosis of colorectal cancer varies in different high-risk conditions. Ann Med. 1998;30:75–80.
38. Peyrin-Biroulet L, Lepage C, Jooste V, et al. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976–2008). Inflamm Bowel Dis. 2012;18:2247–2251.
39. Renz BW, Thasler WE, Preissler G, et al. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis. J Gastrointest Surg. 2013;17:981–990.
40. Adams SV, Ahnen DJ, Baron JA, et al. Survival after inflammatory bowel disease-associated colorectal cancer in the colon cancer family registry. World J Gastroenterol. 2013;19:3241–3248.